MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
HealthStream EPS Ratio 2011-2026 | HSTM
EPS is a measure used to assess the financial stability and profitability of a company. EPS (Earnings Per Share) represents the company's net income divided by the number of its outstanding shares. This measure allows investors and analysts to evaluate the return on investment in the company's stock and compare it to other companies in the industry.
The term earnings per share (EPS) represents the portion of a company's earnings, net of taxes and preferred stock dividends, that is allocated to each share of common stock. The figure can be calculated simply by dividing net income earned in a given reporting period (usually quarterly or annually) by the total number of shares outstanding during the same term. Because the number of shares outstanding can fluctuate, a weighted average is typically used.
Calculated as:
EPS = (Net Income - Dividends on Preffered Stock) / Average Outstanding shares[1]
EPS can be calculated as a simple ratio of net income to shares, or in various variations, such as diluted EPS, which takes into account the potential issuance of new shares or convertible securities.
A high EPS ratio usually indicates that the company has good profitability and efficiency in utilizing its assets. However, other factors such as sales growth, debt burden, and the company's competitive position should also be considered.
EPS ratio is an important indicator for investors when making decisions to buy or sell a company's stock. It is also used by analysts to assess the financial condition of the company and its potential for growth and development.
Annual EPS Ratio HealthStream
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.66 | 0.5 | 0.39 | 0.19 | 0.44 | 0.49 | 1 | 0.31 | 0.12 | 0.29 | 0.38 | 0.31 | 0.29 | 0.31 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1 | 0.12 | 0.406 |
Quarterly EPS Ratio HealthStream
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.2 | 0.18 | 0.14 | - | 0.19 | 0.14 | 0.17 | - | 0.13 | 0.13 | 0.09 | - | 0.12 | 0.1 | 0.09 | - | 0.05 | 0.08 | 0.07 | - | 0.08 | 0.11 | 0.22 | - | 0.11 | 0.07 | 0.18 | - | 0.09 | 0.08 | 0.74 | - | 0.08 | 0.07 | 0.04 | - | 0.04 | 0.04 | 0.05 | - | 0.08 | 0.05 | 0.1 | - | 0.12 | 0.09 | 0.07 | - | 0.08 | 0.09 | 0.07 | - | 0.08 | 0.09 | 0.05 | - | 0.08 | 0.08 | 0.07 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 0.74 | 0.04 | 0.113 |
References
- Khan, T. R., Islam, M. R., Choudhury, T. T., & Adnan, A. M. (2014). How earning per share (EPS) affects on share price and firm value.
EPS Ratio of other stocks in the Health information services industry
| Issuer | EPS Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Accolade
ACCD
|
-1.72 | - | 0.29 % | $ 206 M |  USA |
 |
Change Healthcare
CHNG
|
-0.18 | - | - | $ 9.03 B | USA |
 |
Cerner Corporation
CERN
|
1.86 | - | - | $ 27.9 B | USA |
 |
Health Catalyst
HCAT
|
-2.55 | $ 1.1 | -9.5 % | $ 76.9 M | USA |
 |
American Well Corporation
AMWL
|
-5.96 | $ 5.76 | -0.52 % | $ 92.4 M | USA |
 |
Computer Programs and Systems
CPSI
|
-3.15 | - | 4.4 % | $ 133 M | USA |
 |
Covetrus
CVET
|
-0.39 | - | - | $ 2.94 B | USA |
 |
iCAD
ICAD
|
-0.21 | - | - | $ 102 M | USA |
 |
NextGen Healthcare
NXGN
|
0.14 | - | - | $ 1.6 B | USA |
 |
Omnicell
OMCL
|
0.27 | $ 34.46 | 0.44 % | $ 1.59 B | USA |
 |
1Life Healthcare
ONEM
|
-1.64 | - | - | $ 3.37 B | USA |
 |
OptimizeRx Corporation
OPRX
|
-1.03 | $ 6.78 | 5.44 % | $ 116 M | USA |
 |
HealthEquity
HQY
|
2.5 | $ 82.1 | 0.56 % | $ 7.07 B | USA |
 |
Phreesia
PHR
|
-2.51 | $ 11.28 | -4.41 % | $ 615 M | USA |
 |
Premier
PINC
|
0.22 | - | - | $ 2.33 B | USA |
 |
Evolent Health
EVH
|
-0.2 | $ 2.25 | -9.64 % | $ 211 M | USA |
 |
MTBC
MTBC
|
0.1 | - | -0.58 % | $ 51.7 M | USA |
 |
GoodRx Holdings
GDRX
|
0.04 | $ 2.04 | -1.92 % | $ 787 M | USA |
 |
Schrödinger
SDGR
|
-1.41 | $ 11.57 | -2.53 % | $ 850 M | USA |
 |
Signify Health
SGFY
|
-3.27 | - | -0.02 % | $ 7.21 B | USA |
 |
R1 RCM
RCM
|
-1.86 | - | - | $ 3.81 B | USA |
 |
Akerna Corp.
KERN
|
-0.51 | - | - | $ 161 M | USA |
 |
Allscripts Healthcare Solutions
MDRX
|
1.03 | - | -10.39 % | $ 886 M | USA |
 |
Teladoc Health
TDOC
|
-1.14 | $ 5.42 | -1.09 % | $ 955 M | USA |
 |
NantHealth
NH
|
-8.8 | - | -46.64 % | $ 10.4 M | USA |
 |
Zhongchao
ZCMD
|
-0.12 | $ 1.81 | -4.23 % | $ 9.42 M |  China |
 |
10x Genomics
TXG
|
-2.18 | $ 19.81 | 3.5 % | $ 2.32 B | USA |
 |
Streamline Health Solutions
STRM
|
-2.53 | - | - | $ 21.4 M | USA |
 |
SCWorx Corp.
WORX
|
-0.78 | $ 0.13 | -4.16 % | $ 190 K | USA |
 |
Tabula Rasa HealthCare
TRHC
|
-6.07 | - | - | $ 255 M | USA |
 |
Progyny
PGNY
|
0.12 | $ 18.05 | 0.22 % | $ 1.55 B | USA |
 |
Veeva Systems
VEEV
|
5.55 | $ 179.11 | -3.3 % | $ 29.3 B | USA |